VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes

Filter search : Quote Research All

Reports for search string : Guidance

South Indian Bank Q3FY18: Performance in line; Upside of 25%
SIB earnings were slightly below estimates on back of lower treasury gains, but bank continues to strengthen its core operating performance with improving loan growth to 16-17% (partly due to base eff...
Prabhudas Lilladher, 11 Jan 2018
IT Sector: Q3FY18 results preview
We expect the USD revenue of the IT firms under our coverage universe to post a combined 1.9% QoQ rise in 3QFY18. Top-5 IT firms are expected to post 1.5-3% QoQ rise in USD revenue in reported terms ...
Reliance Securities, 09 Jan 2018
ICICI Bank: Capex recovery still sometime away; retail growth holding well
Capex demand remains muted; maintains 18-20% growth guidance for retailsegment: Credit demand from corporates remains muted and the management is not seeing any signs of capex revival.
Motilal Oswal, 04 Jan 2018
How To Become Your Own Financial Planner?
I strongly believe that one should manage his own money and finances as no one cares about your money more than you do.It’s not that you have to be a certified financial planner or even a finance prof...
elearnmarkets, 18 Dec 2017
Thyrocare Technologies: Seasonality impact diagnostics marginally; Upside of 57%
Maintain ‘Buy’, retain TP at Rs 1,067: The stock trades at PER of 36x and 27x FY18E and FY19E respectively. We expect Thyrocare to achieve 29% growth in revenue and 35% EBITDA margins in FY18E.
Prabhudas Lilladher, 13 Dec 2017
Sadbhav Engineering: Well placed for upcoming opportunity; Buy
SADE sees robust business opportunity coming up in the road sector post the Bharatmala project announcement – the company expects annual awarding from the NHAI to be ~INR800b in FY18 versus INR600b in...
Motilal Oswal, 01 Dec 2017
Capital First: Sailing smooth;Buy for an upside of 33%
The company’s growth prospects appear bullish to us. Given the strong performance in 1HFY18, coupled with better-than-expected demand in the festive season, AUM growth in FY18 should comfortably excee...
Motilal Oswal, 30 Nov 2017
Pharmaceuticals Q2FY18 Results Review
Generics continue to be under pricing pressure and see higher competitive intensity. Average price erosion were 2-4% QoQ and 8-12% YoY.Benefits from key launches: gRenvela tabs/PFOS (Aurobindo), gStra...
Prabhudas Lilladher, 28 Nov 2017
S Chand and Company: 2Q is a non event, annual guidance remains intact; Upside 47.3%  
SCHAND is a CBSE/ICSE focused company deriving more than 80% of business in Q4. The first nine months of financial year is a period of business planning, sampling, marketing, content revision, invento...
Prabhudas Lilladher, 24 Nov 2017
Sun Pharmaceuticals Q2FY18: Domestic business sees partial recovery; Reduce
Sun Pharma’s (SUNP) 2QFY18 sales were in line with EE, while EBITDA and earnings came 10%/48% ahead of EE largely owing to lower R&D and other expenses. US sales declined ~US$ 40mn sequentially due to...
Equirus Securities, 20 Nov 2017
Sun Pharmaceutical Industries Q2FY18 in line; Recall of ANDAs could be precursor to resolution; Reduce
Sun pharma retains its guidance of single-digit decline in sales with 20-22% EBITDA margin. While SUNP had 20% effective tax rate in Q1FY18 and guided for higher tax rate in FY18E, they expects there ...
Prabhudas Lilladher, 16 Nov 2017
Balkrishna Industries Q2 Results: Margins and volume growth to remain strong; retain ADD
BIL’s 2QFY18 volumes grew by a strong 16% yoy and 6% qoq, surprising positively in a seasonally weak quarter. Industry leader Michelin’s specialty tyre sales grew 13% yoy in Sep’17 quarter, pointing t...
Equirus Securities, 14 Nov 2017
L&T Technology Services 2QFY18 Results: Margin recovery could do wonders; retain ADD
L&T Technology Services (LTTS) 2QFY18 earnings were good on revenue but „not so‟ on margins. 2Q US$ revenue growth of 9.2% was led by organic growth (~7.2%, large deal conversion & traction in t...
Equirus Securities, 14 Nov 2017
Torrent Pharma Q2FY18: Expanding domestic footprint with Unichem acquisition - Upgrade to ADD
Torrent Pharmaceutical Limited‟s (TRP) 2QFY18 results were slightly below EE owing to a topline miss due to one-offs in Brazil. However, a strong rebound in the domestic market came as a positiv...
Equirus Securities, 14 Nov 2017
Dr. Lal PathLabs Q2FY18: Operating efficiency, Seasonal tailwind lead growth, margin
Valuation-Downgrade to ‘Accumulate’, reduce TP to Rs963: While cash flow remain strong in pathology business, the scalability of growth remain a challenger given that PE-backed new competitors, intens...
Prabhudas Lilladher, 10 Nov 2017
Jyothy Laboratories Q2FY18: Hold for a long-term investment horizon
The company reported a GST comparable topline growth of 9.6% to Rs430crs. The growth was driven by the Dishwashing and Personal Care categories. Volume grew by 3.5% YoY. Power brands GST comparable gr...
Way2wealth, 10 Nov 2017
eClerx Services Q2FY18: Operating margin defocus was a dampener; Retain REDUCE
A change in margin assumption could moderate return ratios, cash generation and ESL's ability to handsomely reward shareholders. The company's historical premium could be partly attributed to all of t...
Equirus Securities, 10 Nov 2017
Navneet Education Q2FY18: Miss in a seasonally lean quarter; Accumulate
Management continues with their full year publishing guidance in the range of 13‐15% on the back of visibility of syllabus change cycle in key markets of Gujarat and Maharashtra.
Prabhudas Lilladher, 09 Nov 2017
CCL Products India Q2FY18: HOLD the stock with a long-term investment horizon
CCL Products (India) Ltd. (CCL) declared its Q2FY18 results recently. Consolidated net revenues increased by 105.9% to Rs296crs on account of low base in Q2FY17. Volume for H1FY18 grew by ~20% yoy.
Way2wealth, 07 Nov 2017
HCL Technologies Q2FY18 earnings meet estimates
The software firm said consolidated profit for second quarter (July-September) grew 0.8 percent sequentially to Rs 2,188 crore while rupee revenue and dollar revenue increased 2.3 percent each to Rs 1...
SMC, 01 Nov 2017
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: